サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1712512

相互運用可能なヘルスケア情報技術（ヘルスIT）システムの世界市場：2025年～2033年

Global Interoperable Healthcare Information Technology (Health IT) Systems Market - 2025-2033

出版日
ページ情報
英文 165 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
相互運用可能なヘルスケア情報技術（ヘルスIT）システムの世界市場：2025年～2033年
出版日: 2025年04月22日
発行: DataM Intelligence
ページ情報: 英文 165 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の相互運用可能なヘルスケア情報技術（ヘルスIT）システムの市場規模は、2024年に30億8,000万米ドルとなりました。同市場は、2033年には231億8,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは22.3%となる見込みです。

相互運用可能なヘルスケア情報技術（ヘルスIT）システムは、さまざまな医療提供者、医療機関、ITシステム間での安全でシームレスかつ標準化されたヘルスケアデータの交換を促進するデジタルプラットフォームです。これらのシステムは、EHR、検査システム、画像システム、薬局システムなど様々な技術の効果的な連携を可能にします。ヘルスケアにおける相互運用性の第一の目標は、正確で最新の医療情報を提供することによって患者ケアを改善することです。相互運用可能なシステムは、ヘルスケアのエコシステム全体にわたる効率的なコミュニケーションとコラボレーションを通じて、より良い連携をサポートし、検査の重複を減らし、意思決定を強化し、ヘルスケアのアウトカムを改善します。

相互運用可能なヘルスITシステム市場の原動力となっているのは、医療現場全体でシームレスな患者データ交換を行い、より迅速で連携したケアを実現したいというニーズです。これらのソリューションは、臨床上の意思決定を改善し、医療ミスを減少させます。特に北米や欧州などの新興国市場では、政府による義務付けやインセンティブが、接続された医療システムの推進を後押ししています。

こうしたソリューションに対する需要の高まりを受けて、企業は先進的なヘルスITソリューションを発表しています。例えば、2025年3月、eHealth Technologiesは、主要なEHRプロバイダーと統合するヘルスケア技術ソリューション、eヘルスコネクトon FHIRを発表しました。業界標準のFast Healthcare Interoperability Resources（FHIR）に基づくこの統合は、医療システム間の安全でリアルタイムなデータ交換を可能にします。eHealth Connectプラットフォームは、2つのプラットフォーム間で医療記録を検索するためのシームレスな接続を提供します。

相互運用可能なヘルスITシステムを導入するための高額なコストは、システムのアップグレード、インフラの変更、スタッフのトレーニングのための先行投資に直面する中小規模のヘルスケアプロバイダーにとって大きな障壁となっています。また、レガシーシステムと最新プラットフォームとの統合が複雑であることも、特に新興市場における普及の妨げとなっています。

当レポートでは、世界の相互運用可能なヘルスケア情報技術（ヘルスIT）システム市場について調査し、市場の概要とともに、タイプ別、相互運用性レベル別、展開方法別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 タイプ別

  • ソリューション
  • サービス

第6章 相互運用性レベル別

  • 基本的相互運用性
  • 構造的相互運用性
  • セマンティック相互運用性

第7章 展開方法別

  • クラウドベース
  • オンプレミス

第8章 用途別

  • 診断
  • 治療
  • その他

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 地域市場分析と成長機会

  • 北米
    • 地域特有の主要な動向
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 地域特有の主要な動向
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他
  • ラテンアメリカ
    • 地域特有の主要な動向
      • ブラジル
      • アルゼンチン
      • その他
  • アジア太平洋
    • 地域特有の主要な動向
      • 中国
      • インド
      • 日本
      • 韓国
      • その他
  • 中東・アフリカ
    • 地域特有の主要な動向

第11章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • Infor（Koch Industries Inc）
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • Koninklijke Philips NV
  • Cerner Corporation（Oracle Health）
  • Orion Health Group Limited
  • NXGN Management, LLC（NextGen Healthcare）
  • OSP Labs
  • Epic Systems Corporation
  • ViSolve Inc
  • InterSystems Corporation
  • iNTERFACEWARE Inc

第13章 仮定と調査手法

第14章 付録

目次
Product Code: HCIT9505

The global interoperable healthcare information technology (Health IT) Systems market reached US$ 3.08 billion in 2024 and is expected to reach US$ 23.18 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

Interoperable Healthcare Information Technology (Health IT) Systems are digital platforms that facilitate the secure, seamless, and standardized exchange of healthcare data across various providers, institutions, and IT systems. These systems enable the effective collaboration of various technologies like EHRs, lab systems, imaging systems, and pharmacy systems. The primary goal of interoperability in healthcare is to improve patient care by providing accurate, up-to-date medical information. Interoperable systems support better coordination, reduce test duplication, enhance decision-making, and improve healthcare outcomes through efficient communication and collaboration across the healthcare ecosystem. Executive Summary

Market Dynamics: Drivers & Restraints

Rising Need for Seamless Patient Data Exchange

The interoperable healthcare IT systems market is driven by the need for seamless patient data exchange across healthcare settings, enabling faster and more coordinated care. These solutions improve clinical decision-making and reduce medical errors. Government mandates and incentives, particularly in developed markets like North America and Europe, support the push for connected health systems.

With the rising demand for these solutions, companies are launching advanced healthcare IT solutions. For instance, in March 2025, eHealth Technologies launched eHealth Connect on FHIR, a healthcare technology solution that integrates with leading EHR providers. This integration, based on the industry standard Fast Healthcare Interoperability Resources (FHIR), enables secure, real-time data exchange between health systems. The eHealth Connect platform provides a seamless connection for medical record retrieval between the two platforms.

High Implementation and Integration Costs

The high cost of implementing interoperable healthcare IT systems is a significant barrier for small and mid-sized healthcare providers, who face upfront investments for system upgrades, infrastructure changes, and staff training. The complexity of integrating legacy systems with modern platforms can also limit widespread adoption, especially in emerging markets.

Segment Analysis

The global interoperable healthcare information technology (Health IT) systems market is segmented based on type, level of interoperability, deployment method, application, end-user, and region.

Type:

The solutions from the type segment are expected to dominate the interoperable healthcare information technology (Health IT) systems market, with the highest market share

The interoperable healthcare IT systems market focuses on digital platforms, software, and tools that facilitate seamless data sharing and integration across various healthcare systems and providers. These solutions include electronic health record (EHR) interoperability systems, health information exchanges (HIEs), and enterprise data integration tools. The aim is to ensure secure and accurate medical information flow, improve patient outcomes, and reduce redundant procedures, supporting coordinated care.

The interoperable healthcare IT systems market is expanding due to global demand for connected systems, the adoption of interoperability solutions to reduce information silos, improve care transitions, and minimize clinical errors, government mandates and incentive programs in North America and Europe, and the rise in chronic disease prevalence, increasing healthcare data volumes, and the need for efficient medical data exchange in emergencies.

For instance, in February 2025, Edifecs, a global health information technology solutions company, launched its Healthcare Interoperability Cloud. This tool allows payers to strategically manage interoperability and compliance with CMS-9115-F and CMS-0057-F standards. Edifecs was identified as the leading partner for both FHIR and EDI solutions in a study of 99 payers. Since 1996, Edifecs has been instrumental in defining interoperability standards. These factors contribute to the growth of interoperable health IT solutions in the healthcare ecosystem.

Geographical Analysis

North America is expected to hold a significant position in the interoperable healthcare information technology (health IT) systems market with the highest market share

North America is experiencing significant growth in the interoperable healthcare IT systems market, driven by government initiatives, novel platform launches, advanced infrastructure, and high adoption of electronic health records. Regulations like the HITECH Act and the 21st Century Cures Act in the US encourage interoperable systems for secure data exchange. The region also benefits from investments in digital health, supportive reimbursement models, and value-based care. Major health IT companies and the widespread use of mobile health technologies contribute to the demand for interoperability solutions in healthcare settings.

For instance, in March 2025, CommonWell Health Alliance launched the CommonWell Marketplace, a platform aimed at enhancing interoperability and patient care by connecting healthcare providers with innovative solutions, enabling organizations to optimize their nationwide health data exchange priorities.

Competitive Landscape

The major global players in the interoperable healthcare information technology (Health IT) systems market include Infor (Koch Industries Inc), Koninklijke Philips N.V., Cerner Corporation (Oracle Health), Orion Health Group Limited, NXGN Management, LLC (NextGen Healthcare), OSP Labs, Epic Systems Corporation, ViSolve Inc, InterSystems Corporation, and iNTERFACEWARE Inc among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global interoperable healthcare information technology (Health It) systems market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Level of Interoperability
  • 2.5. Snippet by Deployment Method
  • 2.6. Snippet by Application
  • 2.7. Snippet by End User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Need for Seamless Patient Data Exchange
      • 3.1.1.2. Government Initiatives and Regulations
    • 3.1.2. Restraints
      • 3.1.2.1. High Implementation and Integration Costs
      • 3.1.2.2. Data Privacy and Safety Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Growing Investment in Healthcare IT and Infrastructure.
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Solutions*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Services

6. By Level of Interoperability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 6.1.2. Market Attractiveness Index, By Level of Interoperability
  • 6.2. Foundational Interoperability*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Structural Interoperability
  • 6.4. Semantic Interoperability

7. By Deployment Method

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 7.1.2. Market Attractiveness Index, By Deployment Method
  • 7.2. Cloud-Based*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. On-Premise

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Treatment
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Infor (Koch Industries Inc) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Cerner Corporation (Oracle Health)
  • 12.4. Orion Health Group Limited
  • 12.5. NXGN Management, LLC (NextGen Healthcare)
  • 12.6. OSP Labs
  • 12.7. Epic Systems Corporation
  • 12.8. ViSolve Inc
  • 12.9. InterSystems Corporation
  • 12.10. iNTERFACEWARE Inc

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us